Galenica strengthens basic care with new pharmacy concept
Werte in diesem Artikel
Galenica AG
/ Key word(s): Product Launch
Werbung Werbung Press release
Around 1,830 public pharmacies ensure nationwide basic care in Switzerland – more than 300,000 people visit a pharmacy every day. In addition to dispensing medicines, pharmacies increasingly offer services such as vaccinations, health checks and advice for acute complaints. Demographic change and the strained medical supply situation mean that demand for these local easily accessible services continues to grow. Werbung Werbung Galenica develops new pharmacy conceptTo strengthen the role of pharmacies as a central point of contact for health issues, Galenica is working on new care models and the customer experience in pharmacies. A modernised Amavita pharmacy will open in Zurich’s Glattzentrum on 25 October 2025. It will serve as a pilot for a new pharmacy concept that more closely links consultation, store design and digital support. With the launch, Galenica is fundamentally redesigning the customer experience and showing what pharmacies can look like in the future.
The redesigned pharmacy offers express checkouts for quick shopping, fully private rooms for discreet consultations and new semi-private consultation areas. Here, specialists and customers can compare and discuss products and services together on screens. In doing so, Galenica is also responding to changing customer needs: Today, around 80% of customers first obtain information online before visiting a pharmacy. Galenica has been making targeted investments in connecting digital and in-store offerings for several years. The new pharmacy concept is a key component of this strategy.
“As Switzerland’s strongest healthcare network, we want to participate in shaping the role of pharmacies in health and care. To this end, we are investing specifically in modern space concepts, digitalisation, new offers and the further development of employees’ skills,” says Marc Werner, CEO of Galenica. Werbung Werbung Further pharmacies based on the new concept planned for 2026With “Consultation plus,” pharmacies in the Galenica network already offer an easily accessible advisory service, for example for acute concerns such as bladder problems or skin problems as well as preventive health checks such as HerzCheck®. Depending on cantonal regulations, Amavita and Sun Store pharmacies also offer different vaccinations. With the “Cost containment package 2,” the federal government is also underlining the competencies of the pharmacy.
The pharmacy in Glattzentrum is a pilot project that will be implemented with existing staff. Galenica gains insights into customer behaviour, processes and training needs, which are incorporated directly into the further development of the pharmacies. Additional pilot pharmacies are planned for 2026 – as the next step towards broader implementation at other locations.
Dates for the diary
For further information, please contact:
Welcome to the Galenica network!
Galenica is listed on the Swiss Stock Exchange (SIX Swiss Exchange, GALE, security number 36,067,446). Find out more about Galenica at www.galenica.com.
End of Media Release |
Language: | English |
Company: | Galenica AG |
Untermattweg 8 | |
3027 Bern | |
Switzerland | |
Phone: | +41 058 852 81 11 |
E-mail: | info@galenica.com |
Internet: | https://www.galenica.com |
ISIN: | CH0360674466 |
Listed: | SIX Swiss Exchange |
EQS News ID: | 2215604 |
End of News | EQS News Service |
|
2215604 21.10.2025 CET/CEST
Ausgewählte Hebelprodukte auf Galenica
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Galenica
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Galenica AG
Analysen zu Galenica AG
Datum | Rating | Analyst | |
---|---|---|---|
11.02.2013 | Galenica verkaufen | Vontobel Research | |
18.01.2013 | Galenica verkaufen | Vontobel Research | |
03.12.2012 | Galenica reduce | Vontobel Research | |
15.08.2012 | Galenica reduce | Vontobel Research | |
14.08.2012 | Galenica neutral | Sarasin Research |
Datum | Rating | Analyst | |
---|---|---|---|
01.12.2010 | Galenica buy | Vontobel Research | |
17.09.2010 | Galenica buy | Vontobel Research | |
02.09.2010 | Galenica buy | Vontobel Research | |
27.08.2010 | Galenica buy | Vontobel Research | |
18.08.2010 | Galenica buy | Vontobel Research |
Datum | Rating | Analyst | |
---|---|---|---|
14.08.2012 | Galenica neutral | Sarasin Research | |
10.07.2012 | Galenica neutral | Sarasin Research | |
09.07.2012 | Galenica hold | Vontobel Research | |
27.06.2012 | Galenica hold | Vontobel Research | |
13.03.2012 | Galenica neutral | Sarasin Research |
Datum | Rating | Analyst | |
---|---|---|---|
11.02.2013 | Galenica verkaufen | Vontobel Research | |
18.01.2013 | Galenica verkaufen | Vontobel Research | |
03.12.2012 | Galenica reduce | Vontobel Research | |
15.08.2012 | Galenica reduce | Vontobel Research | |
26.07.2012 | Galenica reduce | Vontobel Research |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Galenica AG nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen